Opko Health CEO Phillip Md Et Al Frost Buys 36,000 Shares
Opko Health CEO Phillip Md Et Al Frost bought 36,000 shares of Opko Health stock on the open market in a transaction that occurred on Friday, July 25th.
Weekly CEO Buys Highlight: OPK, LJPC, SFNC, HAFC, TUBE
According to GuruFocus Insider Data , these are the largest CEO buys during the past week.
Wed Jul 23, 2014
Opko Health Stock Price Up 3.7% After Insider Buying Activity
Shares of Opko Health rose 3.7% on Wednesday after an insider bought additional shares in the company, Stock Ratings Network reports.
Tue Jul 22, 2014
Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE
OPKO Health, Inc. , a multinational biopharmaceutical and diagnostics company, today announced that the United States Patent and Trademark Office granted OPKO a patent covering RAYALDEEa , the Company's product to treat secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency.
Thu Jul 17, 2014
Top Insider Buys Highlight: Opko Health Inc.
CEO, Chairman, and 10% Owner of OPKO Health Inc Phillip Frost bought 46,000 shares at an average price of $8.73.
Opko Health CEO Buys $175,200 in Stock
Opko Health CEO Phillip Md Et Al Frost purchased 20,000 shares of Opko Health stock in a transaction that occurred on Wednesday, July 16th.
Fri Jul 11, 2014
Opko Health Sees Unusually-High Trading Volume Following Insider Buying Activity
Opko Health shares saw strong trading volume on Friday after an insider bought additional shares in the company, ARN reports.
Thu Jul 10, 2014
Opko Health Shares Up 2.2% on Insider Buying Activity
Opko Health shares shot up 2.2% during mid-day trading on Thursday after an insider bought additional shares in the company, AnalystRatings.NET reports.
Wed Jul 09, 2014
Press release distribution, EDGAR filing, XBRL, regulatory filings
Resumen: GSMA: los operadores de telecomunicaciones pueden una poltica TIC actualizada y progresiva para impulsar la economa, los trabajos y el bienestar social en Europa )--En la feria Digital Venice 2014 de esta semana, la GSMA y destacados operadores de telecomunicaciones europeos han presentado una declaraciA3n a Matteo Renzi, Prime... )--OPKO ... (more)
OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive...
OPKO Health, Inc. today announced that the European Committee for Orphan Medicinal Products gave a positive opinion recommending the approval of orphan drug designation for OPKO's long-acting version of clotting Factor VIIa for the treatment of bleeding episodes in patients with hemophilia A or B with inhibitors to Factor VIII or Factor IX and ... (more)
Mon Jun 30, 2014
Investors Buy High Volume of Put Options on Opko Health
Opko Health saw some unusual options trading activity on Monday. Investors bought 5,001 put options on the company, American Banking & Market News reports.